Minot Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.11M Buy
4,574
+2,026
+80% +$496K 0.29% 70
2022
Q1
$616K Buy
2,548
+288
+13% +$66.2K 0.13% 113
2021
Q4
$508K Sell
2,260
-6,077
-73% -$1.28M 0.1% 128
2021
Q3
$1.77M Buy
8,337
+1,146
+16% +$264K 0.38% 67
2021
Q2
$1.76M Buy
7,191
+903
+14% +$222K 0.38% 65
2021
Q1
$1.56M Buy
6,288
+249
+4% +$59.4K 0.4% 70
2020
Q4
$1.39M Sell
6,039
-8,206
-58% -$1.89M 0.41% 64
2020
Q3
$3.62M Buy
14,245
+1,816
+15% +$450K 1.36% 23
2020
Q2
$2.93M Buy
12,429
+5,914
+91% +$1.35M 1.46% 27
2020
Q1
$1.32M Buy
+6,515
New +$1.42M 0.95% 37

Other funds holding AMGN

Minot Wealth Management's AMGN Position: Q2 2022 in Review

Minot Wealth Management increased its Amgen (AMGN) stake by 80% in Q2 2022, buying an estimated $496K and bringing the position to 4,574 shares worth $1.11M. The position accounts for 0.29% of the portfolio, ranked #70.

Minot Wealth Management first reported a position in AMGN in Q1 2020 and has held it in 10 quarters since. The position peaked at $3.62M in Q3 2020. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Minot Wealth Management held 4,574 shares of Amgen worth $1.11M as of Q2 2022.
  • Minot Wealth Management bought 2,026 Amgen shares in Q2 2022, an estimated $496K.
  • Amgen made up 0.29% of Minot Wealth Management's portfolio in Q2 2022, its #70 holding.
  • Minot Wealth Management first reported a position in Amgen in Q1 2020 and has held it in 10 quarters since.
  • Minot Wealth Management's Amgen position peaked at $3.62M in Q3 2020.
  • 2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.